Also known as آسٹیوپوروسس مینجمنٹ
Endocrinologist
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Endocrinologist
MBBS, FCPS (Endocrinology), FCPS (Medicine), SCE Endocrinology (London)
Dermatologist
M.B.B.S, M.R.C.P (UK)
Gastroenterologist
M.B.B.S., M.D (Gastro), MACG(America)
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), Specialty Certificate [SCE] in Endocrinology and Diabetes, European Board Examination in Endocrinology, Diabetes and Metabolism [EBEEDM]
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology), Specialty Certificate [SCE] in Endocrinology and Diabetes, European Board Examination in Endocrinology, Diabetes and Metabolism [EBEEDM]
Internal Medicine Specialist
M.B.B.S., F.C.P.S (Medicine), ICMT
Gastroenterologist
M.B.B.S., F.C.P.S (Gastroenterology)
Gastroenterologist
M.B.B.S , F.C.P.S
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures